By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences has been added to the Nasdaq Biotechnology Index.

Nasdaq's semi-annual re-ranking has resulted in six firms being added to the Biotech Index, though PacBio is the only life science tools firm among the new members. The new Index is effective prior to market open on Monday, May 23.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.